QRG CAPITAL MANAGEMENT, INC.

Position in TEVA — Teva Pharmaceutical Industries Ltd

CIK 1996454 BERWYN, PA

Position in TEVA

as of Jun 30, 2026 · filed Jul 14, 2026 Compact

Position Value

$3,017,962

+$724,234 QoQ

Shares Held

89,078

+17.0% QoQ

Ownership

0.008%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

of 65 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Jun 30, 2026

QRG CAPITAL MANAGEMENT, INC. holds $23,691,979 across 10 Drug Manufacturers - Specialty & Generic names. TEVA ranks #5 (12.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TAK	Takeda Pharmaceutical Co Ltd	372,752	$5,975,214
2	ZTS	Zoetis Inc.	54,575	$3,921,759
3	HLN	Haleon plc	383,552	$3,578,540
4	NBIX	Neurocrine Biosciences Inc	18,903	$3,185,911
5	TEVA	Teva Pharmaceutical Industries Ltd This page	89,078	$3,017,962
6	UTHR	UNITED THERAPEUTICS Corp	3,476	$1,883,401
7	VTRS	Viatris Inc	49,564	$787,076
8	RDY	Dr Reddys Laboratories Ltd	41,233	$597,466

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,017,962	89,078	+17.0%	Shares	Sole	2026-07-14
2026-03-31	$2,293,728	76,153	+4.9%	Shares	Sole	2026-04-27
2025-12-31	$2,265,003	72,573	+0.0%	Shares	Sole	2026-02-02
2025-09-30	$1,465,348	72,542	-44.6%	Shares	Sole	2025-10-28
2025-06-30	$2,193,364	130,869	+1.1%	Shares	Sole	2025-07-21
2025-03-31	$1,989,339	129,430	-12.6%	Shares	Sole	2025-04-17
2024-12-31	$3,264,961	148,138	+3.9%	Shares	Sole	2025-02-05
2024-09-30	$2,569,327	142,582	-1.6%	Shares	Sole	2024-10-30
2024-06-30	$2,355,242	144,938	+0.8%	Shares	Sole	2024-07-12
2024-03-31	$2,028,270	143,747	+53.7%	Shares	Sole	2024-05-07
2023-12-31	$976,140	93,500	+10.2%	Shares	Sole	2024-02-07
2023-09-30	$865,164	84,820	—	Shares	Sole	2023-11-13
No filing history on record for this holder in this stock.